Teoresi MedTech is the first entity of the Teoresi Group dedicated to Life Sciences, aiming to contribute to the innovation of the medical sector through a blend of specialized skills and mastery of frontier technologies. It responds to the needs of industry professionals and is driven by the desire to improve patient well-being.
This new organization has emerged from the rebranding of Medicon Ingegneria, the company specialized in the research and design of innovative biomedical devices, which was acquired by the Teoresi Group in 2023.
The new name reflects the synergy between shared goals with the Group and the vision for the future of the MedTech sector. The brand adopts the Group’s name and interprets it in the most representative sense of its consolidated expertise: advanced engineering and cutting-edge technologies applied to the healthcare sector.
The accompanying payoff for the new identity – „Leading advanced medical solutions“ – declares the commitment to propose new standards of excellence in biomedical engineering, developing solutions that not only meet current market needs but also anticipate future challenges, thus contributing to defining new horizons of care and well-being.
From AI for electrocardiogram analysis and diagnostic support, to Computer Vision for tele-rehabilitation, to wearables for patient monitoring, the technological solutions developed by Teoresi MedTech aim to have a high social impact, keeping the patient at the center of all project phases.
Teoresi MedTech is capable of tackling challenges and meeting the most specific needs in the sector, thanks to their highly specialized know-how with unique skills in the development of medical devices. From research, to design, to prototyping and certification, Teoresi MedTech positions the Teoresi Group as a reference industrial partner for companies in the healthcare sector.
Learn more about Teoresi MedTech’s projects and competencies in the new section of our website.